Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cosmeceutical peptides.

Mary P Lupo1, Anna L Cole

  • 1Lupo Center for Aesthetic and General Dermatology, New Orleans, Louisiana, USA. DrLupo@DrMaryLupo.com

Dermatologic Therapy
|November 30, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a Core Outcome Domain Set for Facial Aging.

JAMA dermatology·2026
Same author

Effect of Topical Human Platelet Extract (HPE) for Facial Skin Rejuvenation: A Histological Study of Collagen and Elastin.

Journal of drugs in dermatology : JDD·2024
Same author

Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis.

Dermatology and therapy·2024
Same author

Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.

Aesthetic surgery journal·2021
Same author

The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.

Aesthetic surgery journal·2021
Same author

Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II-induced cutaneous inflammation.

JAAD case reports·2021

Cosmetic peptides are increasingly popular for anti-aging skin treatments. This review covers signal peptides, neurotransmitter-affecting peptides, and carrier peptides, with growing evidence supporting their dermatological use.

Area of Science:

  • Dermatology
  • Cosmeceuticals
  • Biochemistry

Background:

  • Peptide cosmeceuticals represent a novel and popular approach to addressing skin aging.
  • Three primary categories of these peptides exist: signal peptides, neurotransmitter-affecting peptides, and carrier peptides.

Purpose of the Study:

  • To review current popular cosmeceutical peptides.
  • To examine published studies on their theoretical effects.
  • To discuss their practical application in dermatology.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of theoretical mechanisms of action for different peptide types.
  • Evaluation of clinical evidence and practical dermatological use.

Related Experiment Videos

Main Results:

  • Cosmeceutical peptides are categorized into signal, neurotransmitter-affecting, and carrier types.
  • While not as extensively regulated as pharmaceuticals, scientific evidence supporting peptide efficacy is accumulating.
  • The review synthesizes theoretical benefits and practical applications in skincare.

Conclusions:

  • Peptide cosmeceuticals offer promising solutions for aging skin concerns.
  • Further research and clinical validation are ongoing to strengthen the evidence base.
  • These peptides are becoming integral to modern dermatological treatment strategies.